Skip to main content

MEDIFAST INC

For the period ended Mar 31, 2025. Filed Apr 28, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed Apr 28, 2025

MED$13.37+4.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. – Financial Statements

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(U.S. dollars in thousands, except per share amounts)

Three months ended March 31,
20252024
Revenue$115,728$174,739
Cost of sales31,48347,447
Gross profit84,245127,292
Selling, general, and administrative85,507119,352
Income (loss) from operations(1,262)7,940
Other income
Interest income1,3011,223
Other income4872,422
1,7883,645
Income before provision for income taxes52611,585
Provision for income taxes1,2983,269
Net income (loss)$(772)$8,316
Earnings (loss) per share - basic$(0.07)$0.76
Earnings (loss) per share - diluted$(0.07)$0.76
Weighted average shares outstanding
Basic10,94810,909
Diluted10,94810,958

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

(U.S. dollars in thousands)

Three months ended March 31,
20252024
Net income (loss)$(772)$8,316
Other comprehensive income (loss), net of tax:
Foreign currency translation—15
Unrealized income (losses) on investment securities59(241)
59(226)
Comprehensive income (loss)$(713)$8,090
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.